-
The ECG shown above was obtained from a 54-year-old man with atypical chest pain. Is there cause for concern?
-
A rifamycin antibacterial agent has been approved for treating patients with hepatic encephalopathy (HE).
-
Lenient rate control was not inferior to strict rate control in patients with AF in terms of major clinical events.
-
Superficial venous thrombosis is not a benign condition and deserves close attention.
-
-
This study from a surgical ICU in a french university hospital sought to determine the effect on catheterization duration of a daily reminder notifying physicians that the patient had a central venous catheter (CVC) or urinary tract catheter (UTC) and asking whether there was continued need for that catheter.
-
Raurich and colleagues studied 80 patients with acute respiratory distress syndrome (ARDS) to determine whether the alveolar dead-space fraction (VD/VT, the proportion of each breath that does not participate in gas exchange) was a predictor of ultimate survival. The patients were ages 18 years or older, acutely ill in the investigators' ICU, and met the current international diagnostic criteria for ARDS.
-
Casey and colleagues compared the effects on pain, level of consciousness, and vital signs of 2 different doses of remifentanil and placebo for removal of chest drains after cardiac surgery in 60 patients.
-
-
In this issue: Fractures and bisphosphonate therapy, warfarin anticoagulation and influenza vaccine and cotrimoxazole, antiplatelet therapy with clopidogrel and aspirin, FDA Actions.